GGHC
LVGO

Gilder Gagnon Howe & Co’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,454,443
Closed -$204M – 369
2020
Q3 		$204M Sell
1,454,443
-222,251
-13% -$27.1M 1.26% 16
2020
Q2 		$126M Buy
1,676,694
+783,726
+88% +$41M 0.99% 27
2020
Q1 		$25.5M Buy
892,968
+859,418
+2,562% +$22.3M 0.31% 93
2019
Q4 		$841K Sell
33,550
-365,224
-92% -$8.73M 0.01% 231
2019
Q3 		$6.96M Buy
+398,774
New +$12.1M 0.08% 144

Gilder Gagnon Howe & Co's LVGO Position: Q4 2020 in Review

Gilder Gagnon Howe & Co sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 1,454,443 shares — an estimated $204M sold.

Gilder Gagnon Howe & Co first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $204M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • Gilder Gagnon Howe & Co reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 1,454,443 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $204M.
  • Gilder Gagnon Howe & Co first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • Gilder Gagnon Howe & Co's Livongo Health, Inc. Common Stock position peaked at $204M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.